AdaptHealth Corp. (AHCO)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, AdaptHealth Corp. currently loses $2.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 54 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
AdaptHealth’s preliminary results for the second fiscal quarter of 2026, reported August 4, 2026, missed consensus on both revenue and adjusted EPS even as sales rose sharply year over year. Revenue climbed 25.1% to roughly $740.3 million (up from about $591.8 million a year ago), but it trailed the $846.8 million estimate (-12.6%). Adjusted EPS came in at $0.06 versus $0.17 expected (-64%, trailed), up from $0.01 a year ago. Profitability metrics were mixed: gross profit was about $104.2 million, with gross margin at about 14.1%. On cash generation, the company posted operating cash flow of roughly $145.3 million. For the next period, consensus calls for EPS of -$0.05 on revenue of $725.9 million.
About AdaptHealth Corp.
AdaptHealth Corp. provides home-based medical equipment and supplies across the United States, with a focus on patients managing ongoing conditions outside institutional settings. The NASDAQ-listed AHCO operates in healthcare through medical devices and related services, and generated $3.2 billion of revenue in FY2025.
Today's Snapshot
Yesterday AHCO fell 7.9% to 5.70. AdaptHealth disclosed a data breach affecting 4.1 million people.
Trading Volume
Above 10d avg 2.7M
3.5M
vs S&P 500 Today
Strong Underperformance
-7.44%
Updated: September 10, 2026 at 12:09 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$5.98 - $9.28Sell
- RSI (14)37.65Neutral
- Stochastic %K (14, 3, 3)67.22Neutral
- MACD Level (12, 26)-0.52Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.